Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Randomized, Double-blind Placebo-controlled Clinical Study of the Efficacy and Safety of the Vaccine for Prevention of Rotavirus Infection Pentavalent Live With the Participation of Healthy Children

NCT05032391 is registered in ClinicalTrials.gov with Limited Liability Company Pharm Aid as lead sponsor.

NCT NCT05032391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05032391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Randomized, Double-blind Placebo-controlled Clinical Study of the Efficacy and Safety of the Vaccine for Prevention of Rotavirus Infection Pentavalent Live With the Participation of Healthy Children
Lead sponsor
Limited Liability Company Pharm Aid
Phase
Phase 3
Overall status
Completed
Start date
February 22, 2019
Completion date
October 25, 2019
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rotavirus infection